29 Results

People

  1. Sadelain
    Sadelain
  2. Scheinberg
    Scheinberg
  3. Riviere
    Riviere
  4. Jurcic
    Jurcic
  5. Maslak
    Maslak
  6. Mcdevitt
    Mcdevitt
  7. Pinilla
    Pinilla
  8. Brentjens
    Brentjens
  9. Dao
    Dao
  10. Gomez
    Gomez

Groups

  1. Center for Hematologic Malignancies (29)
  2. Department of Medicine (29)
  3. GSK Faculty (29)
  4. Hematologic Malignancies Research (29)
  5. Hematologic Malignancies, Division of (29)
  6. Sloan Kettering Institute Faculty (28)
  7. Molecular Pharmacology and Chemistry Program Faculty (27)
  8. Adult Leukemia (15)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (13)
  10. Radiology, Department of (8)
  1. "Center for Hematologic Malignancies"
  2. "Hematologic Malignancies Research"
  3. "2006"
  4. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (9)
Groups
  1. Center for Hematologic Malignancies (29)
  2. Department of Medicine (29)
  3. GSK Faculty (29)
  4. Hematologic Malignancies Research (29)
  5. Hematologic Malignancies, Division of (29)
  6. Sloan Kettering Institute Faculty (28)

More Groups

People
  1. Michel Sadelain (14)
  2. David Scheinberg (13)
  3. Isabelle Riviere (6)
  4. Javier Pinilla (4)
  5. Joseph Jurcic (4)
  6. Michael Mcdevitt (4)

More People

Years
  1. 2006 (29)
Publications
  1. Blood (6)
  2. Cancer Biotherapy and Radiopharmaceuticals (2)
  3. Journal of Clinical Oncology (2)
  4. Journal of Immunology (2)
  5. Nature Biotechnology (2)
  6. Applied Radiation and Isotopes (1)

More Publications

Publishers
  1. American Society of Hematology (6)
  2. Nature Publishing Group (5)
  3. Mary Ann Liebert, Inc (3)
  4. American Society of Clinical Oncology (2)
  5. Elsevier Inc. (2)
  6. Springer (2)

More Publishers

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Relative biological effectiveness for efficacy and toxicity in leukemia patients of the alpha-particle emitter, bismuth-213
    Meeting Abstract

    Sgouros, G.; Bolch, W. E.; Shah, A.; Watchman, C. J.; Jurcic, J. G.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • CD4+peptide epitopes from the WT1 oncoprotein stimulate CD4+and CD8+T cells that recognize and kill leukemia and solid tumor cells
    Meeting Abstract

    May, R. J.; Pinilla, J.; Korontsvit, T.; Zakhaleva, V.; Zhang, R. H.; Dao, T.; Maslak, P.; Scheinberg, D. A.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Alpha-particle immunotherapy for acute myeloid leukemia (AML) with bismuth-213 and actinium-225
    Meeting Abstract

    Jurcic, J. G.; McDevitt, M. R.; Pandit-Taskar, N.; Divgi, C. R.; Finn, R. D.; Sgouros, G.; Apostalidis, C.; Chanel, S.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • Results of T cell depleted (TCD) allogeneic hematopoietic stem cell transplantation (AlloHSCT) from HLA matched (HLA-M) or partially mismatched (HLA-MM) unrelated donors (URD) in patients with hematologic malignancies: Sustained engraftment and low incidence of graft-vs-host disease (GvHD)
    Meeting Abstract

    Jakubowski, A. A.; Papadopoulos, E. B.; Kernan, N. A.; Boulad, F.; Castro-Malaspina, H. R.; Collins, N. H.; Hsu, K.; Perales, M. A.; Small, T. N.; Van Den Brink, M.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • A panel of artificial antigen presenting cells (AAPC) permits immediate sensitization and rapid generation of virus-specific T-cells of desired HLA restriction for adoptive immunotherapy
    Meeting Abstract

    Hasan, A. N.; Kollen, W. J.; Trivedi, D.; Selvakumar, A.; Sadelain, M.; O'Reilly, R. J.
    Blood (2006)

    Fulltext@MSK | Save
  • Repetitive non-invasive imaging of genetically modified immune and tumor cells in vivo
    Meeting Abstract

    Dobrenkov, K.; Dabrowska, M.; Shenker, L.; Vider, E.; Sadelain, M.; Ponomarev, V.
    Cytotherapy (2006)

    Fulltext@MSK | Save
  • A pilot phase II trial of a synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal residual disease
    Meeting Abstract

    Cortes, J.; Reuben, J. M.; Scheinberg, D.; Lee, B. N.; Gao, H.; Li, C.; Mazanet, R.; Jones, D.; Kantarjian, H.
    Blood (2006)

    Fulltext@MSK | Save
  • Sensitive in vivo detection of primary T cells expressing membrane anchored Gaussia luciferase for the study of adoptive T cell immunotherapy in murine models of malignancy
    Meeting Abstract

    Brentjens, R. J.; Santos, E.; Yeh, R.; La Perle, K.; Toledo-Crow, R.; Nikhamin, Y.; Punzalan, B.; Entenberg, D.; Aranda, I.; Larson, S.; more...
    Blood (2006)

    Fulltext@MSK | Save
  • [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: Cell-level dosimetry and dose-dependent toxicity
    Journal Article

    Zanzonico, P.; Koehne, G.; Gallardo, H. F.; Doubrovin, M.; Doubrovina, E.; Finn, R.; Blasberg, R. G.; Riviere, I.; O'Reilly, R. J.; Sadelain, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2006)

    Fulltext@MSK | Save